Search results
Results from the WOW.Com Content Network
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union .
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near ...
The first Italian region to start with vaccinations was Lazio, in the Spallanzani Hospital in Rome. On 6 January 2021, the European Medicines Agency (EMA) gave the green light to the Moderna vaccine. [208] On 1 May 2021, Italy reached 20 million vaccinated with a single dose and 6 million with double dose. [209] [210] [211]
(Reuters) -The European Union is in talks with Moderna over a new supply deal for the company's COVID-19 vaccines amid concerns over a rise in infections in the region, the Financial Times ...
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated ...
Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan. [9] Stéphane Bancel , the current CEO, was appointed as CEO in 2011. [ 6 ] [ 10 ] Between 2011 and 2017, Moderna raised $2 billion in venture capital funding.
Moderna is up almost 20% in the last month after the company received approval from the FDA for its RSV vaccine for older adults. The biotech firm has enjoyed the spotlight as its brand-new ...